- Home
- AMST vs CARM Comparison
AMST vs CARM Comparison
Compare AMST & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- CARM
- Stock Information
- Founded
- AMST 2017
- CARM 2016
- Country
- AMST United States
- CARM United States
- Employees
- AMST N/A
- CARM N/A
- Industry
- AMST Computer Software: Prepackaged Software
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- AMST Technology
- CARM Health Care
- Exchange
- AMST Nasdaq
- CARM Nasdaq
- Market Cap
- AMST 9.5M
- CARM 8.4M
- IPO Year
- AMST 2020
- CARM N/A
- Fundamental
- Price
- AMST $2.65
- CARM $0.42
- Analyst Decision
- AMST
- CARM Hold
- Analyst Count
- AMST 0
- CARM 5
- Target Price
- AMST N/A
- CARM $0.90
- AVG Volume (30 Days)
- AMST 41.9K
- CARM 42.1M
- Earning Date
- AMST 05-15-2025
- CARM 08-07-2025
- Dividend Yield
- AMST N/A
- CARM N/A
- EPS Growth
- AMST N/A
- CARM N/A
- EPS
- AMST N/A
- CARM N/A
- Revenue
- AMST $82,544.00
- CARM $19,964,000.00
- Revenue This Year
- AMST N/A
- CARM N/A
- Revenue Next Year
- AMST N/A
- CARM N/A
- P/E Ratio
- AMST N/A
- CARM N/A
- Revenue Growth
- AMST N/A
- CARM 32.45
- 52 Week Low
- AMST $2.00
- CARM $0.14
- 52 Week High
- AMST $6.27
- CARM $1.90
- Technical
- Relative Strength Index (RSI)
- AMST 45.78
- CARM 52.02
- Support Level
- AMST $2.67
- CARM $0.41
- Resistance Level
- AMST $2.72
- CARM $0.56
- Average True Range (ATR)
- AMST 0.15
- CARM 0.13
- MACD
- AMST -0.05
- CARM -0.01
- Stochastic Oscillator
- AMST 26.89
- CARM 20.33
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.